The goal of this Phase 3 randomized clinical trial is to compare the efficacy and safety of Belantamab Mafodotin, Pomalidomide, and Dexamethasone against Bortezomib, Pomalidomide, and Dexamethasone.
This trial is currently open and accepting patients.
This study is seeking to enroll approximately 450 participants.
Participants will be randomly assigned into one of two different groups (also called treatment arms). This study is open label, which means that participants and their doctors will know which group they have been placed in.
The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required.
Enrollment: 357 patients (estimated)View More
View all clinical trial locations sorted by state.
If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.
You can explore trial locations from around the US and connect directly with a trial coordinator.Find Nearby Locations
You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.
Still need help? Send us a message